These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3409987)

  • 1. Non-enzymic glycosylation (glycation) of lens proteins by galactose and protection by aspirin and reduced glutathione.
    Huby R; Harding JJ
    Exp Eye Res; 1988 Jul; 47(1):53-9. PubMed ID: 3409987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The non-enzymic glycosylation of bovine lens proteins by glucosamine and its inhibition by aspirin, ibuprofen and glutathione.
    Ajiboye R; Harding JJ
    Exp Eye Res; 1989 Jul; 49(1):31-41. PubMed ID: 2759189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibuprofen, a putative anti-cataract drug, protects the lens against cyanate and galactose.
    Roberts KA; Harding JJ
    Exp Eye Res; 1990 Feb; 50(2):157-64. PubMed ID: 2311679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of aminoguanidine on the glycation (non-enzymic glycosylation) of lens proteins.
    Lewis BS; Harding JJ
    Exp Eye Res; 1990 May; 50(5):463-7. PubMed ID: 2373149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonenzymatic glycosylation (glycation) of lens crystallins in diabetes and aging.
    Abraham EC; Swamy MS; Perry RE
    Prog Clin Biol Res; 1989; 304():123-39. PubMed ID: 2780679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycation of human lens crystallins: effect of age and aspirin treatment.
    Cherian M; Abraham EC
    Ophthalmic Res; 1993; 25(6):349-54. PubMed ID: 8309673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of glucose, galactose and pyridoxal phosphate to lens crystallins.
    Ganea E; Rixon KC; Harding JJ
    Biochim Biophys Acta; 1994 Jul; 1226(3):286-90. PubMed ID: 8054360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylation of lens crystallins: a possible mechanism by which aspirin could prevent cataract formation.
    Rao GN; Lardis MP; Cotlier E
    Biochem Biophys Res Commun; 1985 May; 128(3):1125-32. PubMed ID: 4004853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycation-induced crosslinking of calf lens crystallins.
    van Boekel MA; Hoenders HJ
    Exp Eye Res; 1991 Jul; 53(1):89-94. PubMed ID: 1879506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro glycation and acetylation (by aspirin) of rat crystallins.
    Cherian M; Abraham EC
    Life Sci; 1993; 52(21):1699-707. PubMed ID: 8502115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The major metabolite of bendazac inhibits the glycosylation of soluble lens proteins: a possible mechanism for a delay in cataractogenesis.
    Lewis BS; Harding JJ
    Exp Eye Res; 1988 Aug; 47(2):217-25. PubMed ID: 3409993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma III-crystallin is the primary target of glycation in the bovine lens incubated under physiological conditions.
    Yan H; Willis AC; Harding JJ
    Biochem J; 2003 Sep; 374(Pt 3):677-85. PubMed ID: 12803541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free lysine, glycine, alanine, glutamic acid and aspartic acid reduce the glycation of human lens proteins by galactose.
    Ramakrishnan S; Sulochana KN; Punitham R
    Indian J Biochem Biophys; 1997 Dec; 34(6):518-23. PubMed ID: 9594433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin prevents the nonenzymatic glycosylation and carbamylation of the human eye lens crystallins in vitro.
    Rao GN; Cotlier E
    Biochem Biophys Res Commun; 1988 Mar; 151(3):991-6. PubMed ID: 3355566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of structure, stability and aggregation of soluble lens proteins and alpha-crystallin upon non-enzymatic glycation: The pathomechanisms underlying cataract development in diabetic patients.
    Yousefi R; Javadi S; Amirghofran S; Oryan A; Moosavi-Movahedi AA
    Int J Biol Macromol; 2016 Jan; 82():328-38. PubMed ID: 26478093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycation-induced inactivation of malate dehydrogenase protection by aspirin and a lens molecular chaperone, alpha-crystallin.
    Heath MM; Rixon KC; Harding JJ
    Biochim Biophys Acta; 1996 Apr; 1315(3):176-84. PubMed ID: 8611656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaction of aspirin with cysteinyl residues of lens gamma-crystallins: a mechanism for the proposed anti-cataract effect of aspirin.
    Qin W; Smith JB; Smith DL
    Biochim Biophys Acta; 1993 Apr; 1181(2):103-10. PubMed ID: 8481398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reaction of bovine lens alpha A-crystallin with aspirin.
    Hasan A; Smith JB; Qin W; Smith DL
    Exp Eye Res; 1993 Jul; 57(1):29-35. PubMed ID: 8405169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetyl- L -carnitine decreases glycation of lens proteins: in vitro studies.
    Swamy-Mruthinti S; Carter AL
    Exp Eye Res; 1999 Jul; 69(1):109-15. PubMed ID: 10375455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lens crystallin glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo.
    Swamy MS; Abraham EC
    Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1120-6. PubMed ID: 2525117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.